MedTrace Logo

Effect of Aromatherapy and Music Therapy on Physiological Response and Pain During Mandibular Third Molar Extraction

NCT07647419 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2026-07-17

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effects of aromatherapy and music therapy on physiological responses and intraoperative pain in patients with moderate to severe dental anxiety undergoing mandibular third molar extraction. The main questions it aims to answer are:

* Do aromatherapy and music therapy improve physiological responses during mandibular third molar extraction?
* Are there differences between aromatherapy and music therapy in their effects on physiological parameters and intraoperative pain during mandibular third molar extraction? Researchers will compare an aromatherapy group and a music therapy group with a control group to determine whether these interventions improve physiological responses and reduce intraoperative pain.

Participants will:

* Complete the Modified Dental Anxiety Scale (MDAS) before surgery to determine eligibility.
* Receive aromatherapy, music therapy, or standard care for five minutes before the surgical procedure.
* Undergo measurement of blood pressure, heart rate, and oxygen saturation before and after surgery.
* Report intraoperative pain using a visual analog scale (VAS).

Conditions

  • Dental Anxiety
  • Third Molar Extraction Surgery

Interventions

BEHAVIORAL

Aromatherapy

Participants inhaled 1 mL of lavender essential oil through a gauze pad positioned approximately 2 cm from the nose, avoiding direct contact, for 5 minutes before mandibular third molar extraction.

BEHAVIORAL

Music Therapy

Participants listened to Rachmaninoff - Symphony No. 2, Op. 27, III. Adagio through wireless headphones for 5 minutes before mandibular third molar extraction. The listening volume was selected by the participant.

Sponsors & Collaborators

  • Universidad Científica del Sur

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-02
Primary Completion
2026-06-02
Completion
2026-06-02

Countries

  • Peru

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07647419 on ClinicalTrials.gov